Kendall Park, NJ, United States of America

Suresh B Singh

This inventor holds 74 USPTO granted patents and 19 published patent applications, plus 6 CIPO patents and 32 EPO patents, primarily in ROR-gamma Modulators (CPC class C07D). Top assignees: Vitae Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh, Merck + Co., Inc.. Active years: 2001-2025.

USPTO Granted Patents = 74 (Patent Applications = 19)

% Patents Active = 60.8

CIPO Patents = 6 (Patent Applications = 9)

EPO Patents = 32 (Patent Applications = 45)

Average Co-Inventor Count = 8.8

ph-index = 12

Forward Citations = 409(Granted Patents)

Forward Citations (Not Self Cited) = 227(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

67 out of 85

Vitae Pharmaceuticals, Inc.

patents

14 out of 1,560

Boehringer Ingelheim International Gmbh

Vitae Pharmaceuticals, Inc./boehringer-Ingelheim

patent

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

ROR-gamma

Beta-Secretase

Liver X Receptor

Dihydropyrrolopyridine

Inhibitors

Menin-MLL

Purine Derivatives

Thiazolopyrrolidine

Isoindoline

Cyclic Urea

Heterocycles

Hydroxysteroid Dehydrogenase

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312359 - Inhibitors of the menin-MLL interaction (2025-05-27),

2. 11739085 - Inhibitors of the menin-MLL interaction (2023-08-29),

3. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2022-12-27),

4. 11479557 - Inhibitors of the menin-MLL interaction (2022-10-25),

5. 11008340 - Modulators of ROR-gamma (2021-05-18),

6. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2021-05-11),

7. 10899758 - Inhibitors of the menin-MLL interaction (2021-01-26),

8. 10829481 - Benzimidazole derivatives as modulators of ROR-gamma (2020-11-10),

9. 10829448 - Substituted benzoimidazoles as modulators of ROR-γ (2020-11-10),

10. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2020-10-20),

11. 10683302 - Inhibitors of the menin-MLL interaction (2020-06-16),

12. 10654884 - Purine derivatives as CD73 inhibitors for the treatment of cancer (2020-05-19),

13. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2019-09-03),

14. 10336717 - Inhibitors of beta-secretase (2019-07-02),

15. 10301261 - Substituted indoles as modulators of ROR-gamma (2019-05-28),

Title: The Innovative Journey of Inventor Suresh B Singh

Introduction: Suresh B Singh, a talented inventor based in Kendall Park, NJ (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Suresh B Singh holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patents focus on enhancing cybersecurity measures for IoT devices and improving the efficiency of solar energy systems.

Career Highlights: With a background in electrical engineering and computer science, Suresh B Singh has a successful career spanning over two decades. He has worked for leading tech companies, where he played a key role in developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Suresh B Singh has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life. His collaborative projects have resulted in groundbreaking inventions that have received international recognition.

Conclusion: Suresh B Singh's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators to dream big and create a better future through technology.